DENALI THERAPEUTICS INC (DNLI) Stock Income Statement
USA - NASDAQ:DNLI - US24823R1059 - Common Stock
15.02 USD
+0.61 (+4.23%)
15.02 USD
0 (0%)
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 330.53M | 108.50M | 48.70M | 335.70M | |||
| Gross Premiums Earned | null | null | null | null | null | |||
| Loss Claims | null | null | null | null | null | |||
| Deferred Policy Acquisition Expense | null | null | null | null | null | |||
| Net Interest Income | null | null | null | null | null | |||
| Non Interest Income | null | null | null | null | null | |||
| Loan Loss Provision | null | null | null | null | null | |||
| Net Interest Income after Provision | null | null | null | null | null | |||
| Non Interest Expense | null | null | null | null | null | |||
| Minority Interest Expense | null | null | null | null | null | |||
| Cost Of Goods | null | null | null | null | null | |||
| Gross Profit | null | null | null | null | null | |||
| Operating Expenses | 501.88M | 527.23M | 449.20M | 344.40M | 272.90M | |||
| Research and Development | 396.44M | 423.88M | 358.70M | 265.40M | 212.60M | |||
| Selling, General, and Administrative Expenses | 105.44M | 103.35M | 90.50M | 79.10M | 60.30M | |||
| Operating Income | -501.88M | -196.70M | -340.70M | -295.80M | 62.70M | |||
| Interest Income/Expense | 64.64M | 51.51M | 14.80M | 4.60M | 9.20M | |||
| Other Income/Expense | null | null | null | null | null | |||
| Non Recurring Items | 14.54M | null | null | null | null | |||
| Income Before Taxes | -422.70M | -145.19M | -326.00M | -291.20M | 72.00M | |||
| Income Tax | 68.00K | 30.00K | 0 | -600.00K | 800.00K | |||
| Net Income | -422.77M | -145.22M | -326.00M | -290.60M | 71.10M | |||
| EBITDA | -492.89M | -179.97M | -330.30M | -287.20M | 71.20M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -2.5705 | -1.0572 | -2.6 | -2.39 | 0.63 | |||
| Non GAAP EPS | -2.67 | -1.08 | -2.5999999999999996 | -2.39 | 0.2599999999999998 | |||
| Statistics | ||||||||
| Profit Margin | N/A | -43.94% | -300.46% | -596.71% | 21.18% | |||
| Operating Profit Margin | N/A | -59.51% | -314.01% | -607.39% | 18.68% | |||
All data in USD